NuggMD, the leading telehealth platform for cannabis, has launched in the United Kingdom and integrated with Stripe to reduce friction at the point of sale for prescription-only medical cannabis patients. This move is a core part of the company's strategy to expand into international markets, leveraging Stripe's programmable financial services to simplify online purchases and improve the customer experience.
“We are honored to be launching in the UK and working with Stripe has been a dream. The boundaries that they are pushing in the payments landscape are unmatched,” said NuggMD CEO Charlie Russell.
The integration addresses a key consumer demand: according to a poll by The Cannabis Consumer Poll, NuggMD's in-house pollster, 79% of cannabis consumers expect dispensaries to accept debit card payments. This highlights the importance of digital payment options in the cannabis sector. Russell noted, “Consumers expect the ability to pay for cannabis as easily as they can pay for any other consumer product or service. Stripe’s ability to complete payments faster, more securely, and at a lower cost than traditional methods brings speed, confidence, and savings to the UK’s roughly 75,000 active patients and nearly 700,000 annual prescriptions processed online.”
NuggMD connects patients with licensed medical cannabis practitioners in most U.S. states, the United Kingdom, and Germany. Since its founding in 2015, the company has facilitated more than 2 million medical cannabis evaluations. It also operates The Cannabis Consumer Poll, which surveys a representative sample of consumers in the $47 billion state-legal, regulated cannabis markets.
This expansion into the UK and the Stripe integration mark a significant step for NuggMD, potentially easing access for UK patients who previously faced payment hurdles. For the industry, it demonstrates the growing importance of seamless digital payment solutions in medical cannabis markets worldwide.
